|
Hint
|
Answer
|
|
Pyrethrines (anti-infestation) - scabies
|
Permethrin
|
|
Glucose reducing hormone - very long acting
|
Insulin degludec
|
|
Glucose reducing hormone - very long acting
|
Insulin toujeo
|
|
Glucose reducing hormone - long acting
|
Insulin glargine
|
|
Glucose reducing hormone - long acting
|
Insulin levemir
|
|
Glucose reducing hormone - medium acting
|
Insulin isophane
|
|
Glucose reducing hormone - short acting
|
Insulin aspart
|
|
Glucose reducing hormone - short acting
|
Insulin lispro
|
|
Oral biguanide - increases insulin sensitivity
|
Metformin
|
|
Sulphonylurea - stimulates pancreatic insulin secretion
|
Gliclazide
|
|
Thiazolidinediones - increases insulin sensitivity in muscle and adipose tissue
|
Pioglitazone
|
|
Glucagon-like peptide-1 receptor (GLP-1) agonist - incretin analogue
|
Exenatide
|
|
Glucagon-like peptide-1 receptor (GLP-1) agonist - incretin analogue
|
Liraglutide
|
|
Glucagon-like peptide-1 receptor (GLP-1) agonist - incretin analogue
|
Dulaglutide
|
|
Glucagon-like peptide-1 receptor (GLP-1) agonist - incretin analogue
|
Semaglutide
|
|
Dipeptidyl peptidase-4 (DPP-4) inhibitor - reduces inactivation of incretins
|
Sitagliptin
|
|
Dipeptidyl peptidase-4 (DPP-4) inhibitor - reduces inactivation of incretins
|
Alogliptin
|
|
Dipeptidyl peptidase-4 (DPP-4) inhibitor - reduces inactivation of incretins
|
Linagliptin
|
|
Dipeptidyl peptidase-4 (DPP-4) inhibitor - reduces inactivation of incretins
|
Saxagliptin
|
|
Dipeptidyl peptidase-4 (DPP-4) inhibitor - reduces inactivation of incretins
|
Vildagliptin
|
|
SGLT-2 inhibitor
|
Dapagliflozin
|
|
SGLT-2 inhibitor
|
Canagliflozin
|
|
SGLT-2 inhibitor
|
Empagliflozin
|
|
SGLT-2 inhibitor
|
Ertugliflozin
|
|
PPAR-alpha activator
|
Fenofibrate
|
|
Lipase inhibitor - inhibits uptake of dietary fat
|
Orlistat
|
|
Vasopressin analogue - diabetes insipidus
|
Desmopressin
|
|
Dopamine receptor agonist
|
Cabergoline
|
|
Dopamine receptor agonist
|
Bromocriptine
|
|
T3 thyroid hormone
|
Liothyronine sodium
|
|
T4 thyroid hormone
|
Levothyroxine sodium
|
|
Anti-thyroid drug - hyperthyroidism
|
Propylthiouracil
|
|
Anti-thyroid drug - hyperthyroidism
|
Carbimazole
|
|
Anti-folate anti-proliferative - RA
|
Methotrexate
|
|
Thiopurine anti-proliferative - RA/Crohn's
|
Azathioprine
|
|
Thiopurine anti-proliferative - RA/Crohn's
|
6-mercaptopurine
|
|
Anti-metabolite anti-proliferative - RA
|
Leflunomide
|
|
Cytokine modulators (TNF-alpha blockade) - RA/Crohn's
|
Adalimumab
|
|
Cytokine modulators (TNF-alpha blockade) - RA/Crohn's
|
Etanercept
|
|
Cytokine modulators (TNF-alpha blockade) - RA/Crohn's
|
Infliximab
|
|
Aminosalicylate
|
Mesalazine
|
|
Aminosalicylate
|
Sulfasalazine
|
|
Anti-gout agent
|
Colchicine
|
|
Xanthine oxidase inhibitor
|
Allopurinol
|
|
Xanthine oxidase inhibitor
|
Febuxostat
|
|
NSAID for gout
|
Indomethacin
|
|
Oral combined contraceptive pill
|
Ethinylestradiol with desogestrel
|
|
Oral mini-pill contraceptive
|
Levonorgestrel
|
|
Oral mini-pill contraceptive
|
Desogestrel
|
|
Progesterone receptor modulator - emergency contraception
|
Ulipristal
|
|
Implant contraceptive
|
Etonorgestrel
|
|
Injectable contraceptive
|
Medroxyprogesterone
|
|
Hormone replacement therapy
|
Oestrogen and medroxyprogesterone or noresthisterone
|
|
Essential nutrient in normal pregnancy
|
Folic acid
|
|
Essential nutrient in normal pregnancy
|
Vitamin D
|
|
Labour induction
|
Dinoprostone
|
|
Labour augmentation
|
Oxytocin
|
|
Synthetic opioid analgesic used in labour
|
Pethidine
|
|
Synthetic opioid analgesic used in labour
|
Remifentanil
|
|
Anti-progestogen/prostaglandin - medical termination
|
Mifepristone with misoprostol
|
|
Anti-fibrinolytic - menorrhagic
|
Tranexamic acid
|
|
NSAID - dysmenorrhoea
|
Mefenamic acid
|
|
Alpha-1 blocker
|
Tamsulosin
|
|
Urinary anti-spasmodic (anti-muscarinic)
|
Oxybutynin
|
|
Urinary anti-spasmodic (anti-muscarinic)
|
Solifenacin
|
|
Urinary anti-spasmodic (anti-muscarinic)
|
Tolterodine
|
|
Beta-3 agonist
|
Mirabegron
|
|
Anti-androgens
|
Finasteride
|
|
Phosphodiesterase-5 (PDE5) inhibitor - short-acting
|
Sildenafil
|
|
Phosphodiesterase-5 (PDE5) inhibitor - short-acting
|
Avanafil
|
|
Phosphodiesterase-5 (PDE5) inhibitor - long-acting
|
Tadalafil
|
|
Anti-histamine (H1 receptor blockade)
|
Chlorphenamine
|
|
Anti-histamine (H1 receptor blockade)
|
Loratadine
|
|
Anti-histamine (H1 receptor blockade)
|
Cetirizine
|
|
Corticosteroids for inflammatory diseases
|
Prednisolone
|
|
Corticosteroids for inflammatory diseases
|
Hydrocortisone
|
|
Corticosteroids for inflammatory diseases
|
Dexamethasone
|
|
Calcineurin inhibitor
|
Cyclosporin
|
|
Calcineurin inhibitor
|
Tacrolimus
|
|
Inosine monophosphate dehydrogenase inhibitor - transplants
|
Mycophenolate
|
|
Synthetic G-CSF - neutropenia
|
Filgrastim
|
|
Retinoids
|
Acitretin
|
|
Retinoids
|
Isotretinoin
|
|
Classical alkylating agents - malignancy
|
Cyclophosphamide
|
|
Taxanes - malignancy
|
Paclitaxel
|
|
Taxanes - malignancy
|
Docetaxel
|
|
Anti-pyrimidines - malignancy
|
Fluorouracil
|
|
Anti-pyrimidines - malignancy
|
Cytarabine
|
|
Anti-purines - malignancy
|
Mercaptopurine
|
|
Anti-purines - malignancy
|
Thioguanine
|
|
Anti-neoplastic monoclonal antibodies for early breast cancer
|
Trastuzumab
|
|
Anti-neoplastic monoclonal antibodies for lymphoma
|
Rituximab
|
|
Anti-neoplastic monoclonal antibodies for melanoma
|
Nivolumab
|
|
Immunomodulator - myeloma
|
Lenolidamide
|
|
Selective estrogen receptor modulator (SERM) - breast cancer
|
Tamoxifen
|
|
Luteinising hormone releasing hormone (LHRH) receptor agonist - prostate cancer
|
Goserelin
|
|
Therapeutic hormones - osteoporosis
|
Calcitonin
|
|
Bisphosphonate
|
Alendronate
|
|
Bisphosphonate
|
Pamidronate
|
|
Bisphosphonate
|
Risedronate
|
|
Hypocalcaemia drugs
|
IV Calcium gluconate, vitamin D, PTH
|
|
Hypocalcaemia drugs
|
Teriparatide
|
|
Vitamin D deficiency drugs
|
Colecalciferol (vitamin D3)
|
|
Vitamin D deficiency drugs
|
Calcitriol (1,25-dihydroxyvitamin D)
|
|
Monoclonal antibody for osteoporosis
|
Denosumab
|
|
Oral iron compound
|
Ferrous sulphate
|
|
Vitamin B12 replacement
|
Hydroxocabalamin
|
|
General anaesthetic
|
Propofol
|
|
General anaesthetic
|
Isoflurane
|
|
General anaesthetic
|
Sevoflurane
|
|
NMDA receptor blockade
|
Ketamine
|
|
Local anaesthetic
|
Lidocaine
|
|
Local anaesthetic
|
Bupivacaine
|
|
Local anaesthetic
|
Levobupivacaine
|
|
Neuromuscular blockers (non-depolarising) - paralytic
|
Atracurium besilate
|
|
Neuromuscular blockers (non-depolarising) - paralytic
|
Vecuronium
|
|
Neuromuscular blockers (non-depolarising) - paralytic
|
Rocuronium
|
|
Neuromuscular blockers (depolarising) - paralytic
|
Suxamethonium
|
|
Reversal of neuromuscular block - oligosaccharide
|
Sugammadex
|
|
Reversal of neuromuscular block - peripheral acetylcholinesterase inhibitor
|
Pyridostigmine
|
|
Reversal of neuromuscular block - peripheral acetylcholinesterase inhibitor
|
Neostigmine
|
|
Muscle relaxant - BDZ
|
Temazepam
|
|
Muscle relaxant - alpha-2 agonist
|
Dexmedetomidine
|
|
Muscle relaxant - opioid
|
Alfentanil
|
|
Muscle relaxant - opioid
|
Remifentanil
|
